1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | As a result, C1’s dental appointment was rescheduled to April 11, 2025. Due to low oxygen levels, C1 was subsequently transferred from Kaiser Urgent Care to the University of California Irvine Medical Center Emergency Department (UCI ED). The following day, March 26, 2025, C1 was transferred from UCI ED to Kaiser Hospital, where a diagnosis of moderate calorie malnutrition was made.
On April 4, 2025, C1 was discharged from Kaiser Hospital and returned to the facility. During the hospitalization, C1’s Seroquel prescription was discontinued, a new prescription for Topamax to stimulate appetite was prescribed instead. Upon C1’s return to the facility, both C1’s Conservator and staff observed an improvement in C1’s eating habits, although the appetite had not fully recovered. Kaiser provided physical therapy services, with a therapist visiting two to three times per week. On April 11, 2025, C1 attended the rescheduled dental appointment and was diagnosed with gum disease. However, no direct correlation between this condition and the loss of appetite was identified. Several days after returning to the facility, C1 began to report abdominal pain accompanied by dark stools. On April 10, 2025, Facility Administrator Noel Villegas arranged for C1 to be transported to the Kaiser Emergency Room for evaluation. Hospital staff conducted various tests, all of which yielded negative results. The treating physician recommended a follow-up appointment with a Kaiser Gastroenterologist (GI Specialist). On April 12, 2025, with C1’s Conservator’s consent, the Administrator sought a second medical opinion from Facility Physician, Dr. Patel, who recommended a prescription for Megestrol to stimulate appetite. However, C1’s Conservator declined this prescription due to concerns about potential adverse effects. A follow-up appointment with a Kaiser Gastroenterologist (GI Specialist) was scheduled for April 28, 2025. Interviews conducted with facility staff reported they consistently offered C1 alternative nutritional options such as yogurt, pudding, fruit, chocolate milk, Gatorade, and Ensure to maintain hydration and nutritional intake, even when C1 refused facility-provided meals. C1’s Conservator, Facility Administrator Noel Villegas , and facility staff engaged in ongoing communication and collaborative discussions regarding C1’s decreased appetite and potential interventions. The documented information confirms that the facility staff actively monitored and addressed concerns regarding C1’s diminished appetite. The facility demonstrated continuous efforts to monitor C1’s health and address concerns related to appetite loss and malnutrition. Based on the preponderance of evidence gathered through conducted interviews, medical record reviews, and all pertinent documentation collected by LPA Haddadin, the allegation of "Neglect/Lack of Care and Supervision leading to a loss of appetite and subsequent malnutrition" is found to be Unsubstantiated. This determination indicates that while the alleged incident may have occurred, or the concerns may be valid, there is insufficient evidence to prove that the alleged violation took place.No deficiencies were cited during today's visit. An exit interview was conducted, and a copy of this report was provided. |